TY - JOUR
T1 - Necroptosis-Inducible Polymeric Nanobubbles for Enhanced Cancer Sonoimmunotherapy
AU - Um, Wooram
AU - Ko, Hyewon
AU - You, Dong Gil
AU - Lim, Seungho
AU - Kwak, Gijung
AU - Shim, Man Kyu
AU - Yang, Suah
AU - Lee, Jeongjin
AU - Song, Yeari
AU - Kim, Kwangmeyung
AU - Park, Jae Hyung
PY - 2020/1/1
Y1 - 2020/1/1
N2 - Necroptosis, caspase-independent programmed necrosis, has emerged as a therapeutic target to make dying cancer cells stimulants for antitumor immune responses. The clinical translations exploiting necroptosis, however, have been limited since most cancer cells downregulate receptor-interacting protein kinase 3 (RIPK3) as a key enzyme for necroptosis. Herein, nanobubbles (NBs) that can trigger RIPK3-independent necroptosis, facilitating cell-membrane rupture via the acoustic cavitation effect are reported. The NBs, imbibing perfluoropentane as the gas precursor, are prepared using an amphiphilic polymer conjugate, composed of PEGylated carboxymethyl dextran as the hydrophilic backbone and chlorin e6 as the hydrophobic sonosensitizer. When exposed to ultrasound, the NBs efficiently promote the release of biologically active damage-associated molecular patterns by inducing burst-mediated cell-membrane disintegration. Consequently, the necroptosis-inducible NBs significantly improve antitumor immunity by maturation of dendritic cells and activation of CD8+ cytotoxic T cells both in vitro and in vivo. In addition, the combination of NBs and immune checkpoint blockade leads to complete regression of the primary tumor and beneficial therapeutic activity against metastatic tumors in an RIPK3-deficient CT26 tumor-bearing mouse model. Overall, the innovative NB that causes immunogenic cell death of cancer via RIPK3-independent necroptosis is a promising enhancer for cancer immunotherapy.
AB - Necroptosis, caspase-independent programmed necrosis, has emerged as a therapeutic target to make dying cancer cells stimulants for antitumor immune responses. The clinical translations exploiting necroptosis, however, have been limited since most cancer cells downregulate receptor-interacting protein kinase 3 (RIPK3) as a key enzyme for necroptosis. Herein, nanobubbles (NBs) that can trigger RIPK3-independent necroptosis, facilitating cell-membrane rupture via the acoustic cavitation effect are reported. The NBs, imbibing perfluoropentane as the gas precursor, are prepared using an amphiphilic polymer conjugate, composed of PEGylated carboxymethyl dextran as the hydrophilic backbone and chlorin e6 as the hydrophobic sonosensitizer. When exposed to ultrasound, the NBs efficiently promote the release of biologically active damage-associated molecular patterns by inducing burst-mediated cell-membrane disintegration. Consequently, the necroptosis-inducible NBs significantly improve antitumor immunity by maturation of dendritic cells and activation of CD8+ cytotoxic T cells both in vitro and in vivo. In addition, the combination of NBs and immune checkpoint blockade leads to complete regression of the primary tumor and beneficial therapeutic activity against metastatic tumors in an RIPK3-deficient CT26 tumor-bearing mouse model. Overall, the innovative NB that causes immunogenic cell death of cancer via RIPK3-independent necroptosis is a promising enhancer for cancer immunotherapy.
KW - damage-associated molecular patterns
KW - immune checkpoint blockade
KW - necroptosis
KW - reactive oxygen species
KW - sonodynamic therapy
UR - http://www.scopus.com/inward/record.url?scp=85081540328&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85081540328&partnerID=8YFLogxK
U2 - 10.1002/adma.201907953
DO - 10.1002/adma.201907953
M3 - Article
C2 - 32125731
AN - SCOPUS:85081540328
JO - Advanced Materials
JF - Advanced Materials
SN - 0935-9648
ER -